About Omri Amirav-Drory
Form D filings for resistanceBio in 2024 list Omri Amirav-Drory as director.
Omri Amirav-Drory first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Omri Amirav-Drory in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Omri Amirav-Drory works with at each company, as listed on that company's latest Form D.
resistanceBio, Inc. · Form D, Jan 31, 2024
NG
Nicholas Goldner
Executive officer and director
KL
Kyle Lapham
Chief Executive Officer and director
CB
Christopher Bulow
Executive officer and director